GSK PLC (GS71.DE) Stock Fundamental Analysis

Europe • Frankfurt Stock Exchange • FRA:GS71 • GB00BN7SWP63

25.02 EUR
+0.93 (+3.86%)
Last: Feb 5, 2026, 07:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to GS71. GS71 was compared to 55 industry peers in the Pharmaceuticals industry. While GS71 belongs to the best of the industry regarding profitability, there are concerns on its financial health. GS71 scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • GS71 had positive earnings in the past year.
  • GS71 had a positive operating cash flow in the past year.
  • Each year in the past 5 years GS71 has been profitable.
  • Each year in the past 5 years GS71 had a positive operating cash flow.
GS71.DE Yearly Net Income VS EBIT VS OCF VS FCFGS71.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

1.2 Ratios

  • GS71's Return On Assets of 8.96% is fine compared to the rest of the industry. GS71 outperforms 65.45% of its industry peers.
  • Looking at the Return On Equity, with a value of 34.02%, GS71 belongs to the top of the industry, outperforming 85.45% of the companies in the same industry.
  • GS71 has a better Return On Invested Capital (18.16%) than 81.82% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for GS71 is above the industry average of 14.23%.
Industry RankSector Rank
ROA 8.96%
ROE 34.02%
ROIC 18.16%
ROA(3y)12.52%
ROA(5y)10.05%
ROE(3y)65.63%
ROE(5y)53.08%
ROIC(3y)18.38%
ROIC(5y)14.53%
GS71.DE Yearly ROA, ROE, ROICGS71.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

1.3 Margins

  • With a decent Profit Margin value of 17.08%, GS71 is doing good in the industry, outperforming 67.27% of the companies in the same industry.
  • In the last couple of years the Profit Margin of GS71 has declined.
  • GS71 has a Operating Margin of 26.20%. This is in the better half of the industry: GS71 outperforms 61.82% of its industry peers.
  • GS71's Operating Margin has been stable in the last couple of years.
  • With a Gross Margin value of 72.52%, GS71 perfoms like the industry average, outperforming 52.73% of the companies in the same industry.
  • In the last couple of years the Gross Margin of GS71 has remained more or less at the same level.
Industry RankSector Rank
OM 26.2%
PM (TTM) 17.08%
GM 72.52%
OM growth 3Y3.67%
OM growth 5Y-0.3%
PM growth 3Y-22.68%
PM growth 5Y-9.82%
GM growth 3Y2.09%
GM growth 5Y0.57%
GS71.DE Yearly Profit, Operating, Gross MarginsGS71.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), GS71 is creating value.
  • GS71 has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for GS71 has been increased compared to 5 years ago.
  • Compared to 1 year ago, GS71 has an improved debt to assets ratio.
GS71.DE Yearly Shares OutstandingGS71.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B
GS71.DE Yearly Total Debt VS Total AssetsGS71.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

  • Based on the Altman-Z score of 1.75, we must say that GS71 is in the distress zone and has some risk of bankruptcy.
  • GS71 has a worse Altman-Z score (1.75) than 69.09% of its industry peers.
  • GS71 has a debt to FCF ratio of 3.78. This is a good value and a sign of high solvency as GS71 would need 3.78 years to pay back of all of its debts.
  • GS71 has a Debt to FCF ratio of 3.78. This is comparable to the rest of the industry: GS71 outperforms 56.36% of its industry peers.
  • GS71 has a Debt/Equity ratio of 0.92. This is a neutral value indicating GS71 is somewhat dependend on debt financing.
  • GS71 has a Debt to Equity ratio (0.92) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF 3.78
Altman-Z 1.75
ROIC/WACC2.14
WACC8.5%
GS71.DE Yearly LT Debt VS Equity VS FCFGS71.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B 20B

2.3 Liquidity

  • GS71 has a Current Ratio of 0.84. This is a bad value and indicates that GS71 is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.84, GS71 is doing worse than 85.45% of the companies in the same industry.
  • A Quick Ratio of 0.55 indicates that GS71 may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.55, GS71 is doing worse than 83.64% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.55
GS71.DE Yearly Current Assets VS Current LiabilitesGS71.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 2.73% over the past year.
  • The Earnings Per Share has been growing slightly by 0.56% on average over the past years.
  • Looking at the last year, GS71 shows a small growth in Revenue. The Revenue has grown by 2.73% in the last year.
  • The Revenue has been decreasing by -1.45% on average over the past years.
EPS 1Y (TTM)2.73%
EPS 3Y4.05%
EPS 5Y0.56%
EPS Q2Q%10.66%
Revenue 1Y (TTM)2.73%
Revenue growth 3Y8.31%
Revenue growth 5Y-1.45%
Sales Q2Q%6.68%

3.2 Future

  • Based on estimates for the next years, GS71 will show a small growth in Earnings Per Share. The EPS will grow by 7.25% on average per year.
  • The Revenue is expected to grow by 3.96% on average over the next years.
EPS Next Y8.35%
EPS Next 2Y8.33%
EPS Next 3Y8.41%
EPS Next 5Y7.25%
Revenue Next Year4.28%
Revenue Next 2Y4.69%
Revenue Next 3Y4.66%
Revenue Next 5Y3.96%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
GS71.DE Yearly Revenue VS EstimatesGS71.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B
GS71.DE Yearly EPS VS EstimatesGS71.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • GS71 is valuated correctly with a Price/Earnings ratio of 12.83.
  • GS71's Price/Earnings ratio is a bit cheaper when compared to the industry. GS71 is cheaper than 78.18% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.67, GS71 is valued rather cheaply.
  • The Price/Forward Earnings ratio is 11.63, which indicates a very decent valuation of GS71.
  • GS71's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. GS71 is cheaper than 80.00% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.20, GS71 is valued rather cheaply.
Industry RankSector Rank
PE 12.83
Fwd PE 11.63
GS71.DE Price Earnings VS Forward Price EarningsGS71.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • 98.18% of the companies in the same industry are more expensive than GS71, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, GS71 is valued cheaper than 90.91% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.34
EV/EBITDA 4.87
GS71.DE Per share dataGS71.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of GS71 may justify a higher PE ratio.
PEG (NY)1.54
PEG (5Y)22.85
EPS Next 2Y8.33%
EPS Next 3Y8.41%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. Dividend

5.1 Amount

  • GS71 has a Yearly Dividend Yield of 3.46%.
  • GS71's Dividend Yield is a higher than the industry average which is at 1.95.
  • GS71's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 3.46%

5.2 History

  • The dividend of GS71 decreases each year by -9.84%.
Dividend Growth(5Y)-9.84%
Div Incr Years2
Div Non Decr Years2
GS71.DE Yearly Dividends per shareGS71.DE Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

  • GS71 pays out 46.05% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP46.05%
EPS Next 2Y8.33%
EPS Next 3Y8.41%
GS71.DE Yearly Income VS Free CF VS DividendGS71.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B
GS71.DE Dividend Payout.GS71.DE Dividend Payout, showing the Payout Ratio.GS71.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

GSK PLC

FRA:GS71 (2/5/2026, 7:00:00 PM)

25.02

+0.93 (+3.86%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-29
Earnings (Next)02-04
Inst Owners43.55%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap50.47B
Revenue(TTM)32.17B
Net Income(TTM)5.49B
Analysts70.97
Price Target21.69 (-13.31%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.46%
Yearly Dividend0.69
Dividend Growth(5Y)-9.84%
DP46.05%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.24%
Min EPS beat(2)7.67%
Max EPS beat(2)12.8%
EPS beat(4)4
Avg EPS beat(4)12.2%
Min EPS beat(4)7.67%
Max EPS beat(4)18.46%
EPS beat(8)7
Avg EPS beat(8)10.47%
EPS beat(12)11
Avg EPS beat(12)9.92%
EPS beat(16)15
Avg EPS beat(16)9.75%
Revenue beat(2)0
Avg Revenue beat(2)-0.16%
Min Revenue beat(2)-0.28%
Max Revenue beat(2)-0.04%
Revenue beat(4)1
Avg Revenue beat(4)-0.06%
Min Revenue beat(4)-1.6%
Max Revenue beat(4)1.68%
Revenue beat(8)4
Avg Revenue beat(8)0.89%
Revenue beat(12)7
Avg Revenue beat(12)1.15%
Revenue beat(16)9
Avg Revenue beat(16)-1.83%
PT rev (1m)2.35%
PT rev (3m)12.22%
EPS NQ rev (1m)-2.9%
EPS NQ rev (3m)-5.81%
EPS NY rev (1m)0.68%
EPS NY rev (3m)3.36%
Revenue NQ rev (1m)0.31%
Revenue NQ rev (3m)2.06%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.14%
Valuation
Industry RankSector Rank
PE 12.83
Fwd PE 11.63
P/S 1.36
P/FCF 9.34
P/OCF 5.63
P/B 2.72
P/tB N/A
EV/EBITDA 4.87
EPS(TTM)1.95
EY7.79%
EPS(NY)2.15
Fwd EY8.6%
FCF(TTM)2.68
FCFY10.71%
OCF(TTM)4.44
OCFY17.77%
SpS18.35
BVpS9.21
TBVpS-4.47
PEG (NY)1.54
PEG (5Y)22.85
Graham Number20.1
Profitability
Industry RankSector Rank
ROA 8.96%
ROE 34.02%
ROCE 21.06%
ROIC 18.16%
ROICexc 19.79%
ROICexgc 57.12%
OM 26.2%
PM (TTM) 17.08%
GM 72.52%
FCFM 14.6%
ROA(3y)12.52%
ROA(5y)10.05%
ROE(3y)65.63%
ROE(5y)53.08%
ROIC(3y)18.38%
ROIC(5y)14.53%
ROICexc(3y)22.56%
ROICexc(5y)17.39%
ROICexgc(3y)78.4%
ROICexgc(5y)64.01%
ROCE(3y)21.97%
ROCE(5y)17.32%
ROICexgc growth 3Y9%
ROICexgc growth 5Y1.32%
ROICexc growth 3Y28.26%
ROICexc growth 5Y8.01%
OM growth 3Y3.67%
OM growth 5Y-0.3%
PM growth 3Y-22.68%
PM growth 5Y-9.82%
GM growth 3Y2.09%
GM growth 5Y0.57%
F-Score7
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF 3.78
Debt/EBITDA 1.24
Cap/Depr 87.43%
Cap/Sales 9.62%
Interest Coverage 13.36
Cash Conversion 65.11%
Profit Quality 85.49%
Current Ratio 0.84
Quick Ratio 0.55
Altman-Z 1.75
F-Score7
WACC8.5%
ROIC/WACC2.14
Cap/Depr(3y)108.08%
Cap/Depr(5y)108.56%
Cap/Sales(3y)8.31%
Cap/Sales(5y)9.2%
Profit Quality(3y)87.63%
Profit Quality(5y)97.06%
High Growth Momentum
Growth
EPS 1Y (TTM)2.73%
EPS 3Y4.05%
EPS 5Y0.56%
EPS Q2Q%10.66%
EPS Next Y8.35%
EPS Next 2Y8.33%
EPS Next 3Y8.41%
EPS Next 5Y7.25%
Revenue 1Y (TTM)2.73%
Revenue growth 3Y8.31%
Revenue growth 5Y-1.45%
Sales Q2Q%6.68%
Revenue Next Year4.28%
Revenue Next 2Y4.69%
Revenue Next 3Y4.66%
Revenue Next 5Y3.96%
EBIT growth 1Y6.52%
EBIT growth 3Y12.28%
EBIT growth 5Y-1.74%
EBIT Next Year30.51%
EBIT Next 3Y13.68%
EBIT Next 5Y9.82%
FCF growth 1Y48.4%
FCF growth 3Y-10.73%
FCF growth 5Y-9.42%
OCF growth 1Y42.27%
OCF growth 3Y-6.24%
OCF growth 5Y-3.96%

GSK PLC / GS71.DE FAQ

Can you provide the ChartMill fundamental rating for GSK PLC?

ChartMill assigns a fundamental rating of 5 / 10 to GS71.DE.


What is the valuation status of GSK PLC (GS71.DE) stock?

ChartMill assigns a valuation rating of 7 / 10 to GSK PLC (GS71.DE). This can be considered as Undervalued.


Can you provide the profitability details for GSK PLC?

GSK PLC (GS71.DE) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for GS71 stock?

The Price/Earnings (PE) ratio for GSK PLC (GS71.DE) is 12.83 and the Price/Book (PB) ratio is 2.72.


Can you provide the dividend sustainability for GS71 stock?

The dividend rating of GSK PLC (GS71.DE) is 4 / 10 and the dividend payout ratio is 46.05%.